Bortezomib For Injection (2016-03-18)

Bortezomib for Injection Recall Bortezomib for Injection is being recalled across Canada due to product safety concerns. This medication is used to treat certain types of cancer. The recall affects all bortezomib for injection products distributed in Canada.

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2016-04-08

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/d21e93ad-ff6c-4cc1-872a-c9ccf2d02b29